Abstract
Alzheimer disease is a progressive neurodegenerative brain disorder that leads to major debilitating cognitive deficits. It is believed that the alterations capable of causing brain circuitry dysfunctions have a slow onset and that the full blown disease may take several years to develop. Therefore, it is important to understand the early, asymptomatic, and possible reversible states of the disease with the aim of proposing preventive and disease-modifying therapeutic strategies. It is largely unknown how amyloid β-peptide (Aβ), a principal agent in Alzheimer disease, affects synapses in brain neurons. In this study, we found that similar to other pore-forming neurotoxins, Aβ induced a rapid increase in intracellular calcium and miniature currents, indicating an enhancement in vesicular transmitter release. Significantly, blockade of these effects by low extracellular calcium and a peptide known to act as an inhibitor of the Aβ-induced pore prevented the delayed failure, indicating that Aβ blocks neurotransmission by causing vesicular depletion. This new mechanism for Aβsynaptic toxicity should provide an alternative pathway to search for small molecules that can antagonize these effects of Aβ. © 2010 by The American Society for Biochemistry and Molecular Biology, Inc.
Cite
CITATION STYLE
Parodi, J., Sepúlveda, F. J., Roa, J., Opazo, C., Inestrosa, N. C., & Aguayo, L. G. (2010). β-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. Journal of Biological Chemistry, 285(4), 2506–2514. https://doi.org/10.1074/jbc.M109.030023
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.